Health Impairment From Nasal Airway Obstruction and Changes in Health Utility Values From Septorhinoplasty.


Journal

JAMA facial plastic surgery
ISSN: 2168-6092
Titre abrégé: JAMA Facial Plast Surg
Pays: United States
ID NLM: 101589532

Informations de publication

Date de publication:
01 Mar 2019
Historique:
pubmed: 20 11 2018
medline: 6 2 2020
entrez: 20 11 2018
Statut: ppublish

Résumé

The association of nasal airway obstruction with health is significant, and the health care resources utilized in open septorhinoplasty need to be included in health economic analyses. To describe the association of nasal airway obstruction and subsequent open septorhinoplasty with patient health. A prospective case series study was conducted from September 30, 2009, to October 29, 2015, at 2 tertiary rhinologic centers in Sydney, Australia, among 144 consecutive adult patients (age, ≥18 years) with nasal airway obstruction from septal and nasal valve disorders. Open septorhinoplasty. Patients were assessed before undergoing open septorhinoplasty and then 6 months after the procedure. Health utility values (HUVs) were derived from the 36-Item Short Form Health Survey. Nasal obstruction severity was also measured using the Nasal Obstruction Symptom Evaluation (NOSE) questionnaire and the Sino-Nasal Outcome Test 22 questionnaires. A total of 144 patients (85 women and 59 men; mean [SD] age, 38 [13] years) were assessed. The baseline mean (SD) HUV for patients in this study was 0.72 (0.09), which was below the weighted mean (SD) Australian norm of 0.81 (0.22). After open septorhinoplasty, the mean (SD) HUV improved to 0.78 (0.12) (P < .001). Improvements in HUV were associated with changes in disease-specific patient-reported outcome measures, including Nasal Obstruction Symptom Evaluation scores (r = -0.48; P = .01) and Sino-Nasal Outcome Test 22 scores (r = -0.68; P = .01). Patients with nasal airway obstruction reported baseline HUVs that were lower than the Australian norm and similar to those in individuals with chronic diseases with significant health expenditure. There was a clinically and statistically significant improvement in HUVs after open septorhinoplasty that was associated with a reduction in Nasal Obstruction Symptom Evaluation and Sino-Nasal Outcome Test 22 scores. Outcomes from this study may be used for health economic analyses of the benefit associated with open septorhinoplasty. 4.

Identifiants

pubmed: 30452512
pii: 2714233
doi: 10.1001/jamafacial.2018.1368
pmc: PMC6439790
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

146-151

Références

J Health Econ. 2007 May 1;26(3):597-612
pubmed: 17069909
Health Econ. 2004 Sep;13(9):873-84
pubmed: 15362179
Allergy. 1997;52(40 Suppl):3-6
pubmed: 9353553
Laryngoscope. 2013 Jun;123(6):1341-7
pubmed: 23483522
Health Qual Life Outcomes. 2016 Sep 20;14(1):133
pubmed: 27644755
Auris Nasus Larynx. 2010 Jun;37(3):303-7
pubmed: 19906500
Health Qual Life Outcomes. 2007 Apr 27;5:21
pubmed: 17462100
BMC Public Health. 2004 Oct 07;4:44
pubmed: 15469617
Value Health. 2006 Jul-Aug;9(4):262-71
pubmed: 16903996
Arch Otolaryngol Head Neck Surg. 2010 Mar;136(3):292-5
pubmed: 20231650
Aust N Z J Public Health. 2013 Feb;37(1):7-16
pubmed: 23379800
Health Qual Life Outcomes. 2003 Apr 11;1:4
pubmed: 12737635
Facial Plast Surg. 2010 Aug;26(4):320-7
pubmed: 20665410
Otolaryngol Head Neck Surg. 2004 Feb;130(2):157-63
pubmed: 14990910
Qual Life Res. 2007 May;16(4):661-73
pubmed: 17268926
Laryngoscope. 2014 Jan;124(1):19-23
pubmed: 23670699
Health Qual Life Outcomes. 2009 Mar 31;7:27
pubmed: 19335878
Ann Vasc Surg. 2016 Jul;34:164-70
pubmed: 27177712
Int Forum Allergy Rhinol. 2015 Nov;5(11):1018-27
pubmed: 26140502
Laryngoscope. 2011 Dec;121(12):2672-8
pubmed: 22034223
Ann Rheum Dis. 2009 Dec;68(12):1800-4
pubmed: 19910301
Clin Otolaryngol. 2009 Dec;34(6):518-25
pubmed: 20070760
PLoS Med. 2012;9(9):e1001307
pubmed: 22984353
Health Qual Life Outcomes. 2016 Feb 29;14:31
pubmed: 26922941
Respiration. 2010;79(3):200-8
pubmed: 19478475
Med Care. 1993 Mar;31(3):247-63
pubmed: 8450681
JAMA Facial Plast Surg. 2014 May-Jun;16(3):219-25; quiz 232
pubmed: 24604253
Scand J Rheumatol. 2011 Mar;40(2):108-15
pubmed: 21241197
J Health Econ. 1986 Mar;5(1):1-30
pubmed: 10311607
COPD. 2016 Jun;13(3):380-98
pubmed: 26678545
Clin Otolaryngol. 2009 Oct;34(5):447-54
pubmed: 19793277
Am J Otolaryngol. 1997 Jan-Feb;18(1):29-32
pubmed: 9006674
J Health Econ. 2002 Mar;21(2):271-92
pubmed: 11939242
Qual Life Res. 2005 Jun;14(5):1321-32
pubmed: 16047507
Laryngoscope. 2003 Jul;113(7):1118-22
pubmed: 12838007
Laryngoscope. 2015 May;125(5):1056-61
pubmed: 25431320
JAMA Facial Plast Surg. 2018 Sep 1;20(5):409-418
pubmed: 29801120
Mult Scler. 2017 Jul;23(8):1157-1166
pubmed: 27698247
Aust N Z J Public Health. 2013 Feb;37(1):17-23
pubmed: 23379801
Foot Ankle Int. 2010 Jul;31(7):563-6
pubmed: 20663421
Otolaryngol Head Neck Surg. 2007 May;136(5):736-41
pubmed: 17478207
J Clin Epidemiol. 1998 Nov;51(11):1159-65
pubmed: 9817133
JAMA Facial Plast Surg. 2017 Mar 1;19(2):95-100
pubmed: 27893020

Auteurs

Richard Tjahjono (R)

Rhinology and Skull Base Research Group, Applied Medical Research Centre, University of New South Wales, Sydney, Australia.
University of Sydney Medical School, Sydney, Australia.

Raquel Alvarado (R)

Rhinology and Skull Base Research Group, Applied Medical Research Centre, University of New South Wales, Sydney, Australia.

Larry Kalish (L)

Rhinology and Skull Base Research Group, Applied Medical Research Centre, University of New South Wales, Sydney, Australia.
University of Sydney Medical School, Sydney, Australia.

Raymond Sacks (R)

Rhinology and Skull Base Research Group, Applied Medical Research Centre, University of New South Wales, Sydney, Australia.
University of Sydney Medical School, Sydney, Australia.
Faculty of Medicine and Health Sciences, Macquarie University, Sydney, Australia.

Raewyn Campbell (R)

Rhinology and Skull Base Research Group, Applied Medical Research Centre, University of New South Wales, Sydney, Australia.
University of Sydney Medical School, Sydney, Australia.

George Marcells (G)

Rhinology and Skull Base Research Group, Applied Medical Research Centre, University of New South Wales, Sydney, Australia.

Carolyn Orgain (C)

Rhinology and Skull Base Research Group, Applied Medical Research Centre, University of New South Wales, Sydney, Australia.

Richard John Harvey (RJ)

Rhinology and Skull Base Research Group, Applied Medical Research Centre, University of New South Wales, Sydney, Australia.
Faculty of Medicine and Health Sciences, Macquarie University, Sydney, Australia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH